Skip to main content
Download PDF

Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management

Echo Research & Practice volume 7, pages L1–L4 (2020)Cite this article

References

  1. Harkness A, Ring L, Augustine DX, Oxborough D, Robinson S, Sharma V & Education Committee of the British Society of Echocardiography. Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography. Echo Research and Practice 2020 7 G1–G18. (https://doi.org/10.1530/ERP-19-0050)

    Article  Google Scholar 

  2. Wehner GJ, Jing L, Haggerty CM, Suever JD, Leader JB, Hartzel DN, Kirchner HL, Manus JNA, James N, Ayar Z, et al. Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? European Heart Journal 2020 41 1249–1257. (https://doi.org/10.1093/eurheartj/ehz550)

    Article  Google Scholar 

  3. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography 2015 28 1.e14–39.e14. (https://doi.org/10.1016/j.echo.2014.10.003)

    Article  Google Scholar 

  4. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal - Cardiovascular Imaging 2015 16 233–270. (https://doi.org/10.1093/ehjci/jev014)

    Article  Google Scholar 

  5. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal 2016 37 2129–2200. (https://doi.org/10.1093/eurheartj/ehw128)

    Article  Google Scholar 

  6. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Journal of the American College of Cardiology 2013 62 e147–e239. (https://doi.org/10.1016/j.jacc.2013.05.019)

    Article  Google Scholar 

  7. Kanagala P, Arnold JR, Singh A, Chan DCS, Cheng ASH, Khan JN, Gulsin GS, Yang J, Zhao L, Gupta P, et al. Characterizing heart failure with preserved and reduced ejection fraction: an imaging and plasma biomarker approach. PLoS ONE 2020 15 e0232280. (https://doi.org/10.1371/journal.pone.0232280)

    Article  CAS  Google Scholar 

  8. Streng KW, Nauta JF, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Metra M, Ng LL, et al. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology 2018 271 132–139. (https://doi.org/10.1016/j.ijcard.2018.04.001)

    Article  Google Scholar 

  9. Tromp J, Khan MA, Klip IT, Meyer S, de Boer RA, Jaarsma T, Hillege H, van Veldhuisen DJ, van der Meer P, Voors AA. Biomarker profiles in heart failure patients with preserved and reduced ejection fraction. Journal of the American Heart Association 2017 6 e003989. (https://doi.org/10.1161/JAHA.116.003989)

    Article  Google Scholar 

  10. Tromp J, Khan MAF, Mentz RJ, O’Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, et al. Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC: Heart Failure 2017 5 507–517. (https://doi.org/10.1016/j.jchf.2017.04.007)

    PubMed  Google Scholar 

  11. Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. European Heart Journal 2012 33 1750–1757. (https://doi.org/10.1093/eurheartj/ehr254)

    Article  Google Scholar 

  12. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999 353 9–13. (https://doi.org/10.1016/S0140-6736(98)11181-9)

    Article  Google Scholar 

  13. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine 2004 350 2140–2150. (https://doi.org/10.1056/NEJMoa032423)

    Article  CAS  Google Scholar 

  14. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L & Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine 2005 352 1539–1549. (https://doi.org/10.1056/NEJMoa050496)

    Article  CAS  Google Scholar 

  15. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995 273 1450–1456. (https://doi.org/10.1001/jama.273.18.1450)

    Article  CAS  Google Scholar 

  16. SOLVD Investigators, Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine 1991 325 293–302. (https://doi.org/10.1056/NEJM199108013250501)

    Article  Google Scholar 

  17. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine 2014 371 993–1004. (https://doi.org/10.1056/NEJMoa1409077)

    Article  Google Scholar 

  18. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, et al. Effect of carvedilol on survival in severe chronic heart failure. New England Journal of Medicine 2001 344 1651–1658. (https://doi.org/10.1056/NEJM200105313442201)

    Article  CAS  Google Scholar 

  19. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine 1999 341 709–717. (https://doi.org/10.1056/NEJM199909023411001)

    Article  CAS  Google Scholar 

  20. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L & SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010 376 875–885. (https://doi.org/10.1016/S0140-6736(10)61198-1)

    Article  CAS  Google Scholar 

  21. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. New England Journal of Medicine 1992 327 669–677. (https://doi.org/10.1056/NEJM199209033271001)

    Article  CAS  Google Scholar 

  22. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K & CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003 362 772–776. (https://doi.org/10.1016/S0140-6736(03)14284-5)

    Article  CAS  Google Scholar 

  23. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine 2003 348 1309–1321. (https://doi.org/10.1056/NEJMoa030207)

    Article  CAS  Google Scholar 

  24. Curtis AB, Worley SJ, Adamson PB, Chung ES, Niazi I, Sherfesee L, Shinn T, Sutton MS & Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. IBiventricular pacing for atrioventricular block and systolic dysfunction. New England Journal of Medicine 2013 368 1585–1593. (https://doi.org/10.1056/NEJMoa1210356)

    Article  CAS  Google Scholar 

  25. McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlavek J, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. New England Journal of Medicine 2019 381 1995–2008. (https://doi.org/10.1056/NEJMoa1911303)

    Article  CAS  Google Scholar 

  26. Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, et al. Vericiguat in patients with heart failure and reduced ejection fraction. New England Journal of Medicine 2020 382 1883–1893. (https://doi.org/10.1056/NEJMoa1915928)

    Article  CAS  Google Scholar 

  27. Lupon J, Diez-Lopez C, de Antonio M, Domingo M, Zamora E, Moliner P, Gonzalez B, Santesmases J, Troya MI, Bayes-Genis A. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. European Journal of Heart Failure 2017 19 1615–1623. (https://doi.org/10.1002/ejhf.824)

    Article  Google Scholar 

  28. Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S, Jackson R, Rahneva T, Wage R, Smith G, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet 2019 393 61–73. (https://doi.org/10.1016/S0140-6736(18)32484-X)

    Article  Google Scholar 

  29. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? European Heart Journal 2000 21 1387–1396. (https://doi.org/10.1053/euhj.2000.2011)

    Article  CAS  Google Scholar 

  30. British Society for Heart Failure. British Society of Echocardiography Guideline: Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice. Practical recommendations from the British Society for Heart Failure. London, UK: British Society for Heart Failure, 2020. (available at: https://www.bsh.org.uk/wp-content/uploads/2020/05/Practical-recommendations-from-the-BSH-on-the-BSE-Guideline-V1-PDF.pdf)

    Google Scholar 

Download references

Funding

This work did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

  1. Cardiologist, Liverpool University Hospitals, Liverpool, UK

    Prathap Kanagala MRCP PhD

  2. University of Liverpool, Liverpool, UK

    Prathap Kanagala MRCP PhD

  3. University of Leicester, Leicester, UK

    Prathap Kanagala MRCP PhD

  4. National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Centre, Leicester, UK

    Iain B. Squire FRCP PhD

Authors
  1. Prathap Kanagala MRCP PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iain B. Squire FRCP PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prathap Kanagala MRCP PhD.

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanagala, P., Squire, I.B. Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management. Echo Res Pract 7, L1–L4 (2020). https://doi.org/10.1530/ERP-20-0029

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-20-0029

Echo Research & Practice

ISSN: 2055-0464

Contact us